Ohio Nurse - June 2021
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Page 20 <strong>Ohio</strong> <strong>Nurse</strong> <strong>June</strong> <strong>2021</strong><br />
The Role of Technology and the Improvement of Compliance<br />
with Diabetes Mellitus<br />
Arica Jones<br />
BSN, RN (MSN student, Troy University)<br />
ajones175666@troy.edu<br />
Reprinted with permission from<br />
Alabama <strong>Nurse</strong> May <strong>2021</strong> issue<br />
Scholarly, peer-reviewed articles and studies<br />
published within the past five years were examined<br />
to determine the current state of technology<br />
for diabetes, as well as its effectiveness. The<br />
research found that the combination of modern<br />
technology and education has a profound effect<br />
on glycemic control and is very promising for<br />
improving the overall health of patients. Studies<br />
have heavily incorporated cell phone usage and<br />
mobile applications to enhance patient health<br />
by encouraging personal involvement in their<br />
care, which could ultimately lead to better patient<br />
outcomes.<br />
Dobson, R., Carter, K., Cutfield, R., Hulme, A.,<br />
Hulme, R., McNamara, C., Maddison, R., Murphy,<br />
R., Shepherd, M., Strydom, J., & Whittaker, R.<br />
(2015). Diabetes text-message self-management<br />
support program (SMS4BG): A pilot study. JMIR<br />
Mhealth Uhealth, 3(1), 32. https://doi.org/10.2196/<br />
mhealth.3988<br />
Dobson et al. conducted a nonrandomized<br />
pilot study designed to<br />
implement a mobile health intervention<br />
to control glycemic issues among the<br />
population in Auckland, New Zealand. Fortytwo<br />
consenting participants, with type 1 or<br />
type 2 diabetes, participated over a threemonth<br />
period. The self-management support<br />
for blood glucose (SMS4BG) program was<br />
created to offer mobile health solutions for<br />
the complications of poor glycemic control.<br />
In this study, poorly controlled diabetes<br />
was defined as having a hemoglobin A1c of<br />
8.6% or greater. Inclusion criteria included<br />
possessing a mobile phone, being ages<br />
17-69, and being able to read English. The<br />
participants were referred from healthcare<br />
providers at primary healthcare practices,<br />
secondary care hospitals, and a community-<br />
based organization.<br />
The study affirmed that mobile health<br />
would be beneficial to diabetes management<br />
due to the high percentage of the<br />
population that own a mobile device. The<br />
study consisted of modules that could be<br />
customized by the participant. They could<br />
receive anywhere from 30 text messages<br />
to 461 text messages during the study.<br />
The core module sent two text messages<br />
per month and covered topics such as<br />
diabetes education and stress management.<br />
Participants could also choose to receive<br />
additional information, such as smoking<br />
cessation tips and glucose check reminders.<br />
Thirty-four of the 42 participants opted into<br />
the glucose reminders, which ranged in<br />
frequency from once per week to four times<br />
per day. The glucose reminder messages<br />
allowed participants to reply with their blood<br />
glucose levels, which were then displayed on<br />
a graph for tracking over time.<br />
Thirty-nine of the 42 subjects participated<br />
in the post-study follow-up. A telephone<br />
interview showed that 100% of participants<br />
felt the program was useful, and 97% stated<br />
they would recommend the program to<br />
others. The study resulted in an average<br />
improvement of hemoglobin A1c to 7.1%.<br />
Although this study consisted of a small<br />
sample size, it is still beneficial due to its<br />
patient satisfaction rating and overall patient<br />
outcome.<br />
Garg, S. K., Shah, V. N., Akturk, H. K., Beatson,<br />
C., & Snell-Bergeon, J. K. (2017). Role of mobile<br />
technology to improve diabetes care in adults with<br />
type 1 diabetes: The remote-T1D study iBGStar®<br />
in type 1 diabetes management. Diabetes Therapy,<br />
8(4), 811-819. https://doi.org/10.1007/s13300-017-<br />
0272-5<br />
Garg et al. conducted a study to<br />
determine if mobile technology could lower<br />
the hemoglobin A1c in people with type 1<br />
diabetes. The particular device that was<br />
used in this study was the iBGStar®, which<br />
is a blood glucose meter. This device is<br />
unique because it attaches to a smartphone<br />
and is able to report data directly to the<br />
physician. This device can also be used in<br />
conjunction with the Diabetes Manager app,<br />
which enables it to function as a personal<br />
glucometer. Garg et al. also assessed the<br />
fear of hypoglycemia before and after the<br />
study through a participant questionnaire.<br />
The study was conducted over a six-month<br />
period as a stratified block randomization<br />
that consisted of 100 participants who were<br />
divided into two groups: a control group and<br />
an intervention group. The control group<br />
was given an Accu-Chek Nano® meter,<br />
while the intervention group was provided<br />
with the iBGStar®, an iPhone, and the<br />
Diabetes Manager app. Additionally, all of the<br />
participants were provided with a Dexcom<br />
Seven Plus CGM sensor. All participants<br />
were educated on the use of their assigned<br />
device and glucose logbooks. They were<br />
instructed to check their blood glucose levels<br />
at least three times per day during this sixmonth<br />
period, and they were not allowed to<br />
use their own CGMs or take acetaminophen,<br />
as this would alter the analysis. The<br />
intervention group’s device was set up to<br />
send an alert to the patient’s provider if the<br />
blood glucose level was below 60 or above<br />
300 at any time.<br />
The results of the study were measured<br />
after three months and six months. Although<br />
both groups showed a decrease in their<br />
hemoglobin A1c, there was a substantial<br />
decrease among the intervention group at<br />
the six-month assessment. Garg et al. also<br />
reassessed the fear of hypoglycemia at the<br />
end of the study, but they saw no significant<br />
difference between the initial scores and<br />
the final ones. Over 85% of the participants<br />
in the intervention group were pleased with<br />
the iBGStar® apparatus. They found it to<br />
be more convenient and user friendly than<br />
traditional devices. This study shows how<br />
mobile technology can improve compliance<br />
among those with diabetes. A great deal of<br />
non-compliance comes from not checking<br />
blood glucose levels. This study implemented<br />
routine checks of blood glucose levels, which<br />
made the participants more conscientious of<br />
their results. This, in turn, can promote the<br />
start of healthy behaviors.<br />
Gunawardena, K. C., Jackson, R., Robinett,<br />
I., Dhaniska, L., Jayamanne, S., Kalpani, S.,<br />
& Muthukuda, D. (2019). The influence of the<br />
smart glucose manager mobile application on<br />
diabetes management. Journal of Diabetes<br />
Science and Technology, 13(1), 75-81. https://doi.<br />
org/10.1177/1932296818804522<br />
This randomized controlled study focused<br />
on the population of Sri Lanka and its<br />
prevalence of diabetes mellitus. The country<br />
has seen a 13% increase in cell phone usage<br />
among the population over the last five<br />
years. This prompted Gunawardena et al. to<br />
implement their innovative, technology-based<br />
study to determine if a smartphone app could<br />
positively impact those with diabetes. The<br />
focus of the smart glucose manager (SMG)<br />
app was to provide consistent feedback,<br />
which was believed to have a profound effect<br />
on lowering hemoglobin A1c. The features of<br />
the app included daily reminders to perform<br />
glucose checks, to administer insulin and<br />
other medications, to eat, and to exercise.<br />
The highlights of the app were the abilities<br />
for users to store blood glucose levels to be<br />
graphed over time and to receive feedback<br />
from medical professionals.<br />
The study consisted of 67 participants<br />
between the ages of 18 and 80 years old<br />
with a hemoglobin A1c of 8.0% or higher who<br />
also possessed an Android phone. Exclusion<br />
criteria included those who were pregnant,<br />
on dialysis, had cognitive impairment, or with<br />
steroid-induced diabetes. All participants<br />
had their A1c and BMI checked after three<br />
months and six months. The control group<br />
consisted of 32 participants who were<br />
encouraged to continue their daily diabetes<br />
management routine. The intervention group<br />
comprised 35 individuals with access to the<br />
SMG app.<br />
The study was deemed successful as both<br />
groups showed a significant decrease in<br />
A1c during the first three months. However,<br />
only the intervention group continued to<br />
show a reduction in A1c beyond that. This<br />
study is beneficial because it shows the<br />
positive effects of technology on the selfmanagement<br />
of diabetes.<br />
Hou, C., Carter, B., Hewitt, J., Francisa, T., &<br />
Mayor, S. (2016). Do mobile phone applications<br />
improve glycemic control (HbA1c) in the selfmanagement<br />
of diabetes? A systematic review,<br />
meta-analysis, and GRADE of 14 randomized<br />
trials. Diabetes Care, 39(11), 2089-2095. https://<br />
doi.org/10.2337/dc16-0346<br />
The purpose of this study was to<br />
determine if smartphone applications could<br />
successfully lower and control hemoglobin<br />
A1c and improve the self-management of<br />
diabetes. Hou et al. reviewed 14 previous<br />
studies that included 1,360 total participants.<br />
The 14 studies were selected from five<br />
databases using the keywords cellphones,<br />
mobile applications, and diabetes mellitus.<br />
The search was narrowed further to only<br />
include those studies whose participants<br />
were over the age of 18, had type 1 or type 2<br />
diabetes, and did not already use an app for<br />
diabetes management. Four of the studies<br />
comprised 509 individuals and examined<br />
type 1 diabetes, while the remainder focused<br />
on type 2 diabetes in 851 people. A total of<br />
12 apps were reviewed in the study: three<br />
of which were used for type 1 diabetes, and